← Back to China MedTech Export Radar · Insights
| Metric | Value |
|---|---|
| Evidence-passed manufacturers in current release | 36 |
| With confirmed FDA establishment registration (openFDA match) | 12 |
| Registration activity window | 2026-07-31 → 2026-08-05 |
Every record passes the same evidence gate: a real NMPA UDI registration reference, a company identity check, and - where possible - a cross-market registry match. No guesswork, no fabricated leads.
Chinese med-device manufacturing concentrates in a handful of provinces. This week's evidence-passed pool follows the same pattern:
| Province | Companies |
|---|---|
| Zhejiang | 7 |
| Guangdong | 6 |
| Shanghai | 5 |
| Jiangsu | 4 |
| Beijing | 3 |
| Others | 11 |
| Category | Companies |
|---|---|
| Consumables | 27 |
| Equipment | 6 |
| Equipment + consumables | 2 |
| Others | 1 |
Consumables dominate - the same segment that historically drives most Chinese medical-device exports (syringes, needles, infusion sets, single-use devices, diagnostics consumables).
Get the full list. The China MedTech Export Radar delivers the 30-company pack at USD 369, or the Pro pack with every evidence-passed company in the current release at USD 599 - business emails, official websites, registration references, confidence grades, and a suggested outreach angle per company.
See the packs Download the 3-company sample (XLSX)